CHEK2 and non-small cell lung carcinoma: In addition, univariate analysis demonstrated that the protein expression levels of ATM, ATR, Chk1, Chk2, Cdc25C and total Cdk1 were not significantly associated with a difference in the survival of advanced NSCLC patients (P>0.05).